-Translation- M06/015/17 November 14, 2017 Subject Clarification of Q3/2017 Company Performance To The President of the Stock Exchange of Thailand Reference MDX Public Company Limited and its
: …………................................................................................... Date: ........................................................ Company Letter No.: ................................................ Dear Secretary-General Office of the Securities and Exchange Commission
: …………................................................................................... Date: ........................................................ Company Letter No.: ................................................ Dear Secretary-General Office of the Securities and Exchange Commission
Manager The Stock Exchange of Thailand The operating performance for three-month period end 31 March 2019 of Mahachai Hospital Public Company Limited compared to the prior year was decreasing in net profit
-English translation- M06/006/19 August 14, 2019 Subject Clarification of Q2/2019 Company Performance To The President of the Stock Exchange of Thailand Reference MDX Public Company Limited and its
Manager The Stock Exchange of Thailand The operating performance for three-month period end 30 June 2019 of Mahachai Hospital Public Company Limited compared to the prior year was decreasing in net profit
-Translation- No. M06/011/18 November 14, 2018 Subject Clarification of Q3/2018 Company Performance To The President of the Stock Exchange of Thailand Reference MDX Public Company Limited and its
) Date (Oldest) Notification of Capital Market Supervisory Board TorJor. 47/2558 Regulations on Offer for Sale of Securities through Electronic System or Network (No. 2) http://capital.sec.or.th/webapp/nrs
relevant details to the SEC for approval (Clause 34/5 of the Notification of the Securities and Exchange Commission No. Kor Thor. 19/2561 Re: Rules, Conditions and Procedures for Undertaking Digital
of Section 58 (3) of the Securities and Exchange Act B.E. 2535 (1992), has ordered CMO to arrange a special audit on such irregular transactions by the auditor of the company or any other auditor